Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. (Q54523915)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. |
scientific article |
Statements
Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. (English)
1 reference
José Baselga
1 reference
José Getúlio Martins Segalla
1 reference
Henri Roché
1 reference
Auro Del Giglio
1 reference
Hélio Pinczowski
1 reference
Eva M Ciruelos
1 reference
Sebastião Cabral Filho
1 reference
Patricia Gómez
1 reference
Brigitte Van Eyll
1 reference
Begoña Bermejo
1 reference
Antonio Llombart
1 reference
Bernardo Garicochea
1 reference
Miguel Ángel Climent Durán
1 reference
Paulo Marcelo Gehm Hoff
1 reference
Marc Espié
1 reference
Andre Augusto Junior Gemeinder de Moraes
1 reference
Ronaldo Albuquerque Ribeiro
1 reference
Clarissa Mathias
1 reference
Miguel Gil Gil
1 reference
Belén Ojeda
1 reference
Josefa Morales
1 reference
Sunhee Kwon Ro
1 reference
Shell Li
1 reference
Frederico Costa
1 reference
12 March 2012
1 reference
30
1 reference
13
1 reference
1484-1491
1 reference
Identifiers
1 reference